CCL2 and neoplasm: Biglycan has been demonstrated to trigger the synthesis of the macrophage chemoattractants chemokine (C-C motif) ligand CCL2 and CCL5 [56]; thus, it may be possible that biglycan deficiency modulates tumor vasculature through recruitment of macrophages.